Virtus Investment Advisers’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
EC
RCMNY
PA
BI
NI
Virtus Investment Advisers's ZYME Position: Q2 2026 in Review
Virtus Investment Advisers increased its Zymeworks (ZYME) stake by 375% in Q2 2026, buying an estimated $1.02M and bringing the position to 50,825 shares worth $1.33M. The position accounts for 0.31% of the portfolio, ranked #148.
Virtus Investment Advisers first reported a position in ZYME in Q4 2023 and has held it in 10 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.
- Virtus Investment Advisers held 50,825 shares of Zymeworks worth $1.33M as of Q2 2026.
- Virtus Investment Advisers bought 40,123 Zymeworks shares in Q2 2026, an estimated $1.02M.
- Zymeworks made up 0.31% of Virtus Investment Advisers's portfolio in Q2 2026, its #148 holding.
- Virtus Investment Advisers first reported a position in Zymeworks in Q4 2023 and has held it in 10 quarters since.
- 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.
Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.